An antibody–drug conjugate targeting GPR56 demonstrates efficacy in preclinical models of colorectal cancer
Joan Jacob, Liezl E. Francisco, Treena Chatterjee, Zhengdong Liang, Shraddha Subramanian, Qingyun J. Liu, Julie H. Rowe, Kendra S. Carmon
Topics & Concepts
Colorectal cancerCancer researchAntibody-drug conjugateCytotoxicityCancerCell cultureMedicineBiologyAntibodyMonoclonal antibodyIn vitroImmunologyInternal medicineBiochemistryGeneticsReceptor Mechanisms and SignalingEstrogen and related hormone effectsHER2/EGFR in Cancer Research